Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b study of Chang-Ji-An Capsule in diarrhea-predominant irritable bowel syndrome
ChiCTR2300067891Phase 2Recruiting
- Sponsor
- Beijing Chinese Medicine Hospital Affiliated to Capital Medical University
- Start
- Jun 2022
- Countries
- 1
01
Overview
Phase 2 trial of Changji'an Capsule in Diarrhea-predominant irritable bowel syndrome (IBS-D) (2 arms), sponsored by Beijing Chinese Medicine Hospital Affiliated to Capital Medical University. Primary endpoint: Treatment response rate of diarrhea (fecal trait). Started Jun 2022; status: recruiting.
02
Drugs
Changji'an Capsule
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on ChiCTR2300067891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067891.